Gynazol (Butoconazole Nitrate)

Gynazol is indicated for the treatment of vaginal yeast infections caused by Candida species.

• Confirmed vulvovaginal candidiasis in adult women, based on clinical symptoms and laboratory testing.
• Acute episodes of vaginal itching, burning, and discharge associated with Candida overgrowth.
• Recurrent vulvovaginal candidiasis when standard oral therapy is unsuitable or contraindicated.
• Adjunctive therapy for patients who prefer topical treatment over systemic antifungals.
• Management of mild to moderate Candida infections limited to the vaginal mucosa.
• The medication is applied directly to the vaginal canal, allowing high local concentrations while minimizing systemic exposure.

Local application of Gynazol may cause a range of adverse effects, most of which are mild and resolve after treatment ends. These effects are generally self‑limiting and do not require medical intervention unless they persist.

Common

• Mild vaginal irritation or burning sensation at the site of application.
• Itching or redness of the vulvar skin.
• Unusual vaginal discharge that is watery or slightly cloudy.
• Temporary increase in vaginal odor.
• Mild abdominal cramps or pelvic discomfort.
• Transient spotting or light bleeding after application.

Serious

• Severe allergic reaction with swelling of the face, lips, or throat.
• Persistent or worsening vaginal symptoms suggesting secondary infection.
• Signs of systemic fungal infection such as fever, chills, or malaise.

Before using Gynazol, patients should consider several precautionary measures to ensure safe and effective therapy.

• Verify the diagnosis of vulvovaginal candidiasis with a healthcare professional before initiating treatment.
• Avoid using the product if you have a known hypersensitivity to butoconazole nitrate or other imidazole antifungals.
• Do not apply Gynazol on damaged, inflamed, or ulcerated vaginal tissue.
• Refrain from sexual intercourse, tampon use, or douching for at least 24 hours after each application.
• Inform your clinician if you are pregnant, planning pregnancy, or breastfeeding, as safety data are limited.
• Use caution in patients with a history of recurrent yeast infections or chronic vaginal conditions.

Gynazol may interact with other topical or systemic agents; awareness of potential interactions helps minimize adverse outcomes.

Avoid

• Concurrent use of other vaginal antifungal or antiseptic products, which can increase local irritation.
• Simultaneous application of estrogen‑containing vaginal creams or tablets, as hormonal changes may affect fungal flora.

Use with caution

• Systemic azole antifungals (e.g., fluconazole, itraconazole) because combined antifungal activity may increase risk of toxicity.
• Topical corticosteroids applied to the genital area, which could mask signs of infection.
• Use with lubricants or spermicides that contain non‑oxynol‑9, as they may alter vaginal pH and reduce efficacy.